Beigene, Ltd. (BGNE) SEC Filing 8-K Material Event for the period ending Monday, October 22, 2018

Beigene, Ltd.

CIK: 1651308 Ticker: BGNE

View differences made from one to another to evaluate Beigene, Ltd.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Beigene, Ltd..


Assess how Beigene, Ltd.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Beigene, Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Beigene, Ltd. provided additional information to their SEC Filing as exhibits

Ticker: BGNE
CIK: 1651308
Form Type: 8-K Corporate News
Accession Number: 0001171843-18-007233
Submitted to the SEC: Thu Oct 25 2018 4:01:18 PM EST
Accepted by the SEC: Thu Oct 25 2018
Period: Monday, October 22, 2018
Industry: Pharmaceutical Preparations
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: